Modification of the Release Profiles of Theophylline Matrix Tablets by inclusion of Water Leachable or Water Swellable Excipients
Article Sidebar
Main Article Content
Abstract
Matrix system is an attractive oral controlled release dosage form due to convenience in process development and low production. This study was undertaken to investigate the effects of leaching and swelling agents on sustained release theophylline tablets. Twelve batches of theophylline matrix tablets were prepared with ten batches containing varied amount of the swellant or channeling agents. The matrix tablets were prepared by either melt granulation or simple coacervation technique. Release studies were carried out for 12 h in 0.1 N HCl. Data obtained were fitted into zero order, first order, Higuchi and Korsmeyer equations. The initial release after 60 min and maximum release from only carnauba wax and Eudragit based tablets were 13%, 50% and 12.5%, 46% respectively. With the inclusion of 10% sucrose, these values were increased to 22%, 80% and 22%, 86% respectively. Both the rate and extent of release were significantly increased with the inclusion of either channeling agents or swellant. Kinetic study revealed that the mechanism of release was mainly by diffusion and partly by erosion. Thus, the inclusion of excipients in the right proportion can produce matrix tablets with desired release profiles.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Barnes PJ (2010). Theophylline: A review. Pharmaceuticals. 3(3): 725 – 747
Barnes PJ (2013). Theophylline. Amm J Resp Cri Med. 188: 901 – 906
Bhagwat RR and Vaidhya SI (2013). Novel drug delivery systems. An overview. International J Pharm Sci and Res. 4(3): 970 – 982
Damodharan N, Mothilal M, Madhavi M and Thejomayananthan P (2009). Formulation and evaluation of bi-layered floating tablets of theophylline. Der Pharmacia letter, 1(2): 227 - 233.
Gad S, Ghorab M, Khafagy E and Kamel M (2012). Formulation, characterization and comparative in vitro - in vivo evaluation of sustained release theophylline tablets. International Journal of Pharmacy and Pharmaceutical Sciences, 4(3): 721 - 728.
Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuka Y, et al. (2005). Formulation study and drug release mechanism of a new theophylline sustained release preparation. Int J Pharm.304: 91 – 101.
Nokhodchi A, Raja S, Patel P, Asare-Addo K (2012). The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts. 2(4):175 – 187
Razzak SM, Khan F, Khan ZR Fatema K, Islam MS and Reza S (2008). Effect of channeling agents on the release profile of theophylline from METHOCEL K4M based matrix tablets. Dhaka Univ. J. Pharm. Sci.7(1): 27 – 32.
Rios ZA, Ghaly ES (2015). The effect of formulation excipients and thermal treatment on the release properties of Lisinopril spheres and tablets. BioMed Res Int. Vol 2015, article ID 423615.
Roy H, Brahma C, Nandi S and Parida KR (2013). Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers. Int J Appl Bio Med Res. 3(1): 55 – 63.
Sammour RMF, Farah FH, Shahiwala A (2015). Publication trend of different novel drug delivery systems during 1980 – 2012: A pilot study using Pubmed search tool. IOSR – JPBS. 4(1): 01 – 08.
Sarojini S, Arivazagan D, Manavalan R, Jayanthi V (2010). Buoyant sustained release tablets based on polyethylene oxide. Int J Pharm Pharm Sci. 2 suppl 1: 144 – 149.
Schultz A, Martin AC (2013). Outpatients management of asthma in children. Clin Med Ins: Ped. 7: 13 – 34.
Shannon M (2000). Theophylline: its rise, demise and resurrection. Clin Ped Emerg Med; 217 – 221.
Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P and Bannerjee SK (2012). Drug delivery systems: An updated review. Int J Pharm Investig. 2(1): 2 – 11.
Vo AQ, Feng X, Morrott JT, Pimparade MB, Tiwari RV, Zhang F and Repka MA (2016). A novel floating controlled release drug delivery system prepared by melt extrusion. Eu J Pharm and Biopharm. 98: 108 – 121